Genome-wide circulating microRNA expression profiling indicates biomarkers for epilepsy

Area of Science:

• Biochemistry
• Genetics
• Neurology

Background:

• MicroRNAs (miRNAs) are stable molecules in serum, proposed as disease biomarkers.
• Epilepsy diagnosis lacks noninvasive biomarkers; circulating miRNAs in humans remain understudied.
• Current epilepsy diagnostics require improvement for better patient outcomes.

Purpose of the Study:

• To investigate circulating miRNA profiles in epilepsy patients.
• To identify potential serum miRNA biomarkers for epilepsy diagnosis.
• To evaluate the diagnostic value of specific miRNAs in epilepsy.

Main Methods:

• Serum samples from 30 epilepsy patients and 30 controls were analyzed using Illumina sequencing and qRT-PCR.
• miRNA expression differences were identified in a discovery/training phase.
• Selected miRNAs were validated in a larger cohort (117 patients, 112 controls) via qRT-PCR.

Main Results:

• Six miRNAs (let-7d-5p, miR-106b-5p, -130a-3p, -146a-5p, -15a-5p, -194-5p) showed significant differential expression (P < 0.0001).
• miR-106b-5p exhibited the highest diagnostic potential, with 80.3% sensitivity and 81.2% specificity.
• Circulating miRNA levels are demonstrably altered in epilepsy patients.

Conclusions:

• Circulating miRNAs are differentially regulated in epilepsy.
• miR-106b-5p shows promise as a novel, noninvasive biomarker for epilepsy diagnosis.
• This finding could lead to improved diagnostic strategies for epilepsy.